<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A proportion of cytogenetic abnormalities in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) may escape detection by high-resolution genomic technologies, but can be identified by conventional cytogenetic and molecular analysis </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we report the detection of a reciprocal translocation t(7;21)(p22;q22) in the marrow of two adults with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, using conventional cytogenetic analysis and fluorescence-in situ-hybridization (FISH) </plain></SENT>
<SENT sid="2" pm="."><plain>Reverse-transcription polymerase chain reaction (RT-PCR) and sequence analysis identified a fusion between RUNX1 and the gene encoding ubiquitin specific peptidase-42 (USP42), with splice-variants and variable break-points within RUNX1 </plain></SENT>
<SENT sid="3" pm="."><plain>Combined cytomorphology and FISH studies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow revealed abnormal RUNX1 signals within megakaryocytes, suggesting that the acquisition of t(7;21)(p22;q22) does not confer complete differentiation arrest and may represent an early genetic event in leukaemogenesis </plain></SENT>
<SENT sid="4" pm="."><plain>Single nucleotide polymorphism-arrays failed to detect additional sub-microscopic genomic changes predisposing to or associated with t(7;21) </plain></SENT>
<SENT sid="5" pm="."><plain>Molecular analysis of 100 MDS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> marrow specimens by RT-PCR did not reveal new cases with the RUNX1-USP42 fusion </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, our studies have identified t(7;21)(p22;q22) as a rare but recurrent abnormality in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, with the existence of alternative spliced forms of the RUNX1-USP42 transcript in different patients </plain></SENT>
<SENT sid="7" pm="."><plain>Further studies are required to identify the potential contribution of these splice-variants to disease <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
</text></document>